MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10620-020-06533-7

Медицинская библиотека · Digestive diseases and sciences · 2020

Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study.

Hyun Hye Kyung, Cho Eun Ju, Park Soo Young, Hong Young Mi, Kim Soon Sun, Kim Hwi Young, Heo Nae-Yun, Park Jung Gil, Sinn Dong Hyun, Kang Wonseok, Jeong Song Won, Song Myeong Jun, Park Hana, Lee Danbi, Lee Yong Sun, Cho Sung Bum, An Chan Sik, Rhee Hyung Jin, Lee Hyun Woong, Kim Beom Kyung, Park Jun Yong, Kim Do Young, Ahn Sang Hoon, Han Kwang-Hyub, Lee Jeong-Hoon, Yu Su Jong, Kim Yoon Jun, Yoon Jung-Hwan, Tak Won Young, Kweon Young Oh, Yoon Ki Tae, Cho Mong, Cheong Jae Youn, Park Seung Ha, Kim Seung Up, Korean TACE Study Group

СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND AND AIMS: The influence of direct-acting antivirals (DAAs) on chronic hepatitis C (CHC)-related hepatocellular carcinoma (HCC) remains controversial. We investigated the effect of eradicating CHC using DAAs on treatment outcomes in patients with CHC-related HCC treated with transarterial chemoembolization (TACE).

METHODS

This nationwide, multi-center, retrospective study recruited patients with CHC-related HCC treated with TACE as the first-line anti-cancer treatment, and who achieved a sustained virological response (SVR) using DAAs (DAA group) between 2006 and 2017. Patients achieving an SVR following interferon-based treatment (IFN group) and those without treatment (control group) were also recruited for comparison.

RESULTS

A total of 425 patients were eligible for the study. Of these, 356 (83.8%), 26 (6.1%), and 43 (10.1%) were allocated to the control, IFN, and DAA groups, respectively. A multivariate analysis showed that liver cirrhosis, segmental portal vein thrombosis, and larger maximal tumor size independently predicted an increased risk of progression (all p < 0.05), whereas, the DAA group (vs. IFN and control groups) independently predicted a reduced risk of progression (hazard ratio (HR) = 0.630, 95% confidence interval 0.411-0.966, p = 0.034). The cumulative incidence rate of HCC progression in the DAA group was significantly lower than that in the IFN and control groups (p = 0.033, log-rank test). In addition, the DAA group (vs. IFN and control groups) was independently associated with a reduced risk of mortality (p = 0.042).

CONCLUSIONS

DAA treatment provided significantly prolonged progression-free survival in patients with CHC-related HCC treated with TACE compared to that in patients administered IFN or no treatment.

Для цитирования: Hyun Hye Kyung, Cho Eun Ju, Park Soo Young, Hong Young Mi, Kim Soon Sun, Kim Hwi Young, Heo Nae-Yun, Park Jung Gil, Sinn Dong Hyun, Kang Wonseok, Jeong Song Won, Song Myeong Jun, Park Hana, Lee Danbi, Lee Yong Sun, Cho Sung Bum, An Chan Sik, Rhee Hyung Jin, Lee Hyun Woong, Kim Beom Kyung, Park Jun Yong, Kim Do Young, Ahn Sang Hoon, Han Kwang-Hyub, Lee Jeong-Hoon, Yu Su Jong, Kim Yoon Jun, Yoon Jung-Hwan, Tak Won Young, Kweon Young Oh, Yoon Ki Tae, Cho Mong, Cheong Jae Youn, Park Seung Ha, Kim Seung Up, Korean TACE Study Group. Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study.. Digestive diseases and sciences. 2020. DOI: 10.1007/s10620-020-06533-7.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.